GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.

Being realistic, responsive and transparent is key in engaging unresponsive and underperforming clinical trial sites; that ...

The performance data below gives an overall summary of how sectors have performed over the past 12 months (although note those sectors don’t always map precisely onto our FTSE 350 groupings). General ...